You are here

Article Text

Article menu
Download PDFPDF
Letter
Response to: ‘Acupuncture for chemotherapy-induced peripheral neuropathy: a randomised controlled pilot study’
  1. Jun Kako1,
  2. Kohei Kajiwara1,
  3. Masamitsu Kobayashi2,
  4. Yasufumi Oosono2 and
  5. Hiroko Noto3
  1. 1 Division of Nursing Science, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
  2. 2 Community Health Nursing, National Defense Medical College, Tokorozawa, Japan
  3. 3 Department of Health Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  1. Correspondence to Jun Kako, Division of Nursing Science, Hiroshima University, Hiroshima, Japan; jkako-tky{at}umin.ac.jp

https://doi.org/10.1136/bmjspcare-2019-001976

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Dear Editor

    We have read, with great interest, the recent paper titled ‘Acupuncture for chemotherapy-induced peripheral neuropathy: a randomised controlled pilot study’ by D'Alessandro et al,1 which evaluated the effect of acupuncture treatment on chemotherapy-induced peripheral neuropathy (CIPN). We would like to highlight additional points of discussion regarding this study.

    The author reported that the primary aim of their study was to evaluate the effect of acupuncture treatment in reducing the neurological symptoms of …

    View Full Text

    Footnotes

    • Contributors JK, KK, MK, YO and HN made substantial contributions to study conception and design. JK and KK were involved in drafting the manuscript. All authors have given final approval of the version to be published.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; internally peer reviewed.